Key result
Berberine prolongs ventricular action potential duration by selectively blocking IKr with ~4 µM IC50.
Why the study?
The specific effects of the antiarrhythmic drug berberine on action potential duration and individual ionic currents in cat ventricular myocytes were investigated.
Answers are grounded in this paper and cite their sources.
Berberine may prolong ventricular repolarization via IKr inhibition; leaves open its net antiarrhythmic efficacy and safety in humans.
In the present work, the effects of the antiarrhythmic drug, berberine, on action potential and ionic currents of cat ventricular myocytes were studied. 2. Berberine prolonged action potential duration in cat ventricular myocytes without altering other variables of the action potential. 3. The drug at concentrations of 0.3-30 microM blocked only the delayed rectifier (IK) current with an IC50 = 4.1 microM. Berberine produced a tonic block and a phasic block that was increased with the duration of the depolarizing pulse. The blocking effect on IK was use-dependent, but not frequency-dependent. 4. In cardiac preparations two delayed rectifier currents have been found: a rapid (IKr) current and a slow (IKs) current. In the present work it has been found that berberine at the concentrations used, selectively blocked IKr. 5. At concentrations higher than 10 microM it also decreased the transient outward (Ito1) current. The drug did not have effects on the inward rectifier (IK1) or the high threshold calcium current (Ica-L). 6. These results show that berberine is a specific potassium channel blocker. The increase in action potential duration induced by berberine can be explained mainly by its blocking effects on IK.
No takes yet. Share an insight, caveat, or question.
José A. Sánchez‐Chapula (1996) studied this question. Berberine was evaluated on Action potential duration and delayed rectifier outward current (IK) inhibition (IC50 4.1 microM). Berberine (0.3-30 microM) prolonged action potential duration in cat ventricular myocytes by selectively blocking the rapid delayed rectifier potassium current (IKr) with an IC50 of 4.1 microM.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: